Thermo Fisher Scientific Ranibizumab Humanized Recombinant Human Monoclonal Antibody

Applications

• ELISA (ELISA)
  Tested Dilution: 1:5,000–1:10,000

Product Specifications

Product Specific Information

• Endotoxin level < 0.01 EU/µg by LAL method
• Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
• Store at 2–8°C for one week.
• Store at -20 to -80°C for twelve months from the date of receipt.

Target Information

Ranibizumab (trade name Lucentis) is an FDA-approved drug for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO).
It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment that binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.